Mechanisms of resistance to trastuzumab as neoadjuvant therapy in women with HER2-overexpressing operable breast cancer.

被引：0
|
作者：
Jinno, Hiromitsu
Sato, Tomomi
Hayashida, Tetsu
Takahashi, Maiko
Hirose, Shigemichi
Kitagawa, Yuko
机构：
[1] Keio Univ, Sch Med, Tokyo, Japan
[2] Keio Univ, Sch Med, Dept Surg, Tokyo 160, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e11060
引用
收藏
页数：1
相关论文
共 50 条
  • [21] TBCRC 006: A multicenter phase II study of neoadjuvant lapatinib and trastuzumab in patients with HER2-overexpressing breast cancer
    Chang, J. C. N.
    Mayer, I. A.
    Forero-Torres, A.
    Nanda, R.
    Goetz, M. P.
    Rodriguez, A. A.
    Pavlick, A. C.
    Wang, T.
    Hilsenbeck, S. G.
    Gutierrez, C.
    Schiff, R.
    Osborne, C. K.
    Rimawi, M. F.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [22] Predictive factors of resistance to trastuzumab as neoadjuvant therapy in women with HER2-positive breast cancer
    Jinno, Hiromitsu
    Sato, Tomomi
    Takahashi, Maiko
    Hayashida, Tetsu
    Hirose, Shigemichi
    Kitagawa, Yuko
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (26)
  • [23] Therapeutic strategies and mechanisms of tumorigenesis of HER2-overexpressing breast cancer
    Emde, Anna
    Koestler, Wolfgang J.
    Yarden, Yosef
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2012, 84 : E49 - E57
  • [24] Treatment of HER2-overexpressing breast cancer
    Baselga, J.
    ANNALS OF ONCOLOGY, 2010, 21 : 36 - 40
  • [25] Weekly Gemcitabine and Trastuzumab in the Treatment of Patients With HER2-Overexpressing Metastatic Breast Cancer
    Yardley, Denise A.
    Burris, Howard A., III
    Hanson, Sarah
    Greco, F. Anthony
    Spigel, David R.
    Barton, John
    Hainsworth, John D.
    CLINICAL BREAST CANCER, 2009, 9 (03) : 178 - 183
  • [26] Tolerability and activity of trastuzumab in elderly patients with HER2-overexpressing metastatic breast cancer
    Zucchini, G.
    Bernardi, A.
    Martoni, A.
    Zamagni, C.
    ANNALS OF ONCOLOGY, 2013, 24 (01) : 264 - 265
  • [27] Trastuzumab-targeted gene delivery to Her2-overexpressing breast cancer cells
    K Mann
    M Kullberg
    Cancer Gene Therapy, 2016, 23 : 221 - 228
  • [28] Trastuzumab induces gastrointestinal side effects in HER2-overexpressing breast cancer patients
    Noor Al-Dasooqi
    Joanne M. Bowen
    Rachel J. Gibson
    Thomas Sullivan
    Jude Lees
    Dorothy M. Keefe
    Investigational New Drugs, 2009, 27 : 173 - 178
  • [29] Trastuzumab induces gastrointestinal side effects in HER2-overexpressing breast cancer patients
    Al-Dasooqi, Noor
    Bowen, Joanne M.
    Gibson, Rachel J.
    Sullivan, Thomas
    Lees, Jude
    Keefe, Dorothy M.
    INVESTIGATIONAL NEW DRUGS, 2009, 27 (02) : 173 - 178
  • [30] Cardiac toxicity of trastuzumab-related regimens in HER2-overexpressing breast cancer
    Ewer, Michael S.
    O'Shaughnessy, Joyce A.
    CLINICAL BREAST CANCER, 2007, 7 (08) : 600 - 607
12345